COVID-19

We, as patients, consumers, taxpayers, health care providers, payers, and members of the pharmaceutical and medical device pipeline, are ready to work with The President's Administration to ensure that America’s patients and our health care system receive the treatments they need throughout this public health crisis.

As representatives of the drug supply and payment chain, ranging from pharmaceutical manufacturers, pharmacies, specialty pharmacies, managed care pharmacy, pharmacy benefit managers (PBMs), to health plans, we are aligned on the important principle that the private sector and state and federal governments must work together to facilitate Americans’ reliable access to needed prescription drugs during the COVID-19 pandemic.

These are trying times, especially for health care practitioners. Together, as managed care pharmacy professionals, we face challenges to patient care. AMCP CEO Susan A. Cantrell, RPh, CAE addresses these unique challenges in her latest blog post.